EUVIMEDEUVIMED entdecken
Crossref

Durable Response To Capecitabine (Xeloda; Roche) In An Elderly Patient With Liver And Bone Metastases Of Breast Cancer

The Internet Journal of Oncology · 2006

DOI: 10.5580/1752 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Internet Journal of Oncology, 2006.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This case report concerns an elderly patient with liver and bone metastases of breast cancer successfully treated for two-years with capecitabine as first line chemotherapy without any side effect.

Zitieren

APA

(2006). Durable Response To Capecitabine (Xeloda; Roche) In An Elderly Patient With Liver And Bone Metastases Of Breast Cancer. The Internet Journal of Oncology. https://doi.org/10.5580/1752

Vancouver

Durable Response To Capecitabine (Xeloda; Roche) In An Elderly Patient With Liver And Bone Metastases Of Breast Cancer. The Internet Journal of Oncology. 2006. doi:10.5580/1752

BibTeX
@article{euvimed2006,
  title = {Durable Response To Capecitabine (Xeloda; Roche) In An Elderly Patient With Liver And Bone Metastases Of Breast Cancer},
  journal = {The Internet Journal of Oncology},
  year = {2006},
  doi = {10.5580/1752}
}
Kostenlos starten →